699 related articles for article (PubMed ID: 35674109)
1. Cellular senescence and the tumour microenvironment.
Takasugi M; Yoshida Y; Ohtani N
Mol Oncol; 2022 Sep; 16(18):3333-3351. PubMed ID: 35674109
[TBL] [Abstract][Full Text] [Related]
2. The role of cellular senescence and SASP in tumour microenvironment.
Takasugi M; Yoshida Y; Hara E; Ohtani N
FEBS J; 2023 Mar; 290(5):1348-1361. PubMed ID: 35106956
[TBL] [Abstract][Full Text] [Related]
3. Effects of senescence on the tumour microenvironment and response to therapy.
Reynolds LE; Maallin S; Haston S; Martinez-Barbera JP; Hodivala-Dilke KM; Pedrosa AR
FEBS J; 2024 Jun; 291(11):2306-2319. PubMed ID: 37873605
[TBL] [Abstract][Full Text] [Related]
4. Senescent cells and SASP in cancer microenvironment: New approaches in cancer therapy.
Özdemir A; Şimay Demir YD; Yeşilyurt ZE; Ark M
Adv Protein Chem Struct Biol; 2023; 133():115-158. PubMed ID: 36707199
[TBL] [Abstract][Full Text] [Related]
5. Assessing Functional Roles of the Senescence-Associated Secretory Phenotype (SASP).
Malaquin N; Tu V; Rodier F
Methods Mol Biol; 2019; 1896():45-55. PubMed ID: 30474839
[TBL] [Abstract][Full Text] [Related]
6. The roles and mechanisms of senescence-associated secretory phenotype (SASP): can it be controlled by senolysis?
Ohtani N
Inflamm Regen; 2022 Apr; 42(1):11. PubMed ID: 35365245
[TBL] [Abstract][Full Text] [Related]
7. Senescence and Immunotherapy: Redundant Immunomodulatory Pathways Promote Resistance.
Oesterreich S; Aird KM
Cancer Immunol Res; 2023 Apr; 11(4):401-404. PubMed ID: 36826438
[TBL] [Abstract][Full Text] [Related]
8. Reshaping of the tumor microenvironment by cellular senescence: An opportunity for senotherapies.
D'Ambrosio M; Gil J
Dev Cell; 2023 Jun; 58(12):1007-1021. PubMed ID: 37339603
[TBL] [Abstract][Full Text] [Related]
9. Overcoming the senescence-associated secretory phenotype (SASP): a complex mechanism of resistance in the treatment of cancer.
Chambers CR; Ritchie S; Pereira BA; Timpson P
Mol Oncol; 2021 Dec; 15(12):3242-3255. PubMed ID: 34137158
[TBL] [Abstract][Full Text] [Related]
10. Targeting cellular senescence with senotherapeutics: senolytics and senomorphics.
Zhang L; Pitcher LE; Prahalad V; Niedernhofer LJ; Robbins PD
FEBS J; 2023 Mar; 290(5):1362-1383. PubMed ID: 35015337
[TBL] [Abstract][Full Text] [Related]
11. The Emergence of Senescent Surface Biomarkers as Senotherapeutic Targets.
Rossi M; Abdelmohsen K
Cells; 2021 Jul; 10(7):. PubMed ID: 34359910
[TBL] [Abstract][Full Text] [Related]
12. Senescence and the tumor-immune landscape: Implications for cancer immunotherapy.
Chibaya L; Snyder J; Ruscetti M
Semin Cancer Biol; 2022 Nov; 86(Pt 3):827-845. PubMed ID: 35143990
[TBL] [Abstract][Full Text] [Related]
13. Dynamic and scalable assessment of the senescence-associated secretory phenotype (SASP).
Malaquin N; Rodier F
Methods Cell Biol; 2024; 181():181-195. PubMed ID: 38302239
[TBL] [Abstract][Full Text] [Related]
14. Aging microenvironment and antitumor immunity for geriatric oncology: the landscape and future implications.
Zhao B; Wu B; Feng N; Zhang X; Zhang X; Wei Y; Zhang W
J Hematol Oncol; 2023 Mar; 16(1):28. PubMed ID: 36945046
[TBL] [Abstract][Full Text] [Related]
15. Cellular senescence in the lung across the age spectrum.
Parikh P; Wicher S; Khandalavala K; Pabelick CM; Britt RD; Prakash YS
Am J Physiol Lung Cell Mol Physiol; 2019 May; 316(5):L826-L842. PubMed ID: 30785345
[TBL] [Abstract][Full Text] [Related]
16. Senescent Cells in Cancer: Wanted or Unwanted Citizens.
Niklander SE; Lambert DW; Hunter KD
Cells; 2021 Nov; 10(12):. PubMed ID: 34943822
[TBL] [Abstract][Full Text] [Related]
17. Adamantinomatous craniopharyngioma as a model to understand paracrine and senescence-induced tumourigenesis.
Gonzalez-Meljem JM; Martinez-Barbera JP
Cell Mol Life Sci; 2021 May; 78(10):4521-4544. PubMed ID: 34019103
[TBL] [Abstract][Full Text] [Related]
18. Paracrine roles of cellular senescence in promoting tumourigenesis.
Gonzalez-Meljem JM; Apps JR; Fraser HC; Martinez-Barbera JP
Br J Cancer; 2018 May; 118(10):1283-1288. PubMed ID: 29670296
[TBL] [Abstract][Full Text] [Related]
19. Prognostic and therapeutic potential of senescent stromal fibroblasts in prostate cancer.
Mori JO; Elhussin I; Brennen WN; Graham MK; Lotan TL; Yates CC; De Marzo AM; Denmeade SR; Yegnasubramanian S; Nelson WG; Denis GV; Platz EA; Meeker AK; Heaphy CM
Nat Rev Urol; 2024 May; 21(5):258-273. PubMed ID: 37907729
[TBL] [Abstract][Full Text] [Related]
20. Deciphering the mechanism for induction of senescence-associated secretory phenotype (SASP) and its role in ageing and cancer development.
Ohtani N
J Biochem; 2019 Oct; 166(4):289-295. PubMed ID: 31297533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]